KAS
SLS icon

Kestra Advisory Services’s SELLAS Life Sciences SLS Stock Holding History

Kestra Advisory Services’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$516K Buy
34,980
+5,830
+20% +$40.2K ﹤0.01% 2321
2026
Q1 		$123K Buy
29,150
+1,750
+6% +$7.83K ﹤0.01% 3008
2025
Q4 		$103K Buy
27,400
+1,000
+4% +$1.94K ﹤0.01% 3393
2025
Q3 		$42.5K Buy
+26,400
New +$47K ﹤0.01% 2867

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Kestra Advisory Services's SLS Position: Q2 2026 in Review

Kestra Advisory Services increased its SELLAS Life Sciences (SLS) stake by 20% in Q2 2026, buying an estimated $40.2K and bringing the position to 34,980 shares worth $516K. The position accounts for ﹤0.01% of the portfolio, ranked #2321.

Kestra Advisory Services first reported a position in SLS in Q3 2025 and has held it in 4 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Kestra Advisory Services held 34,980 shares of SELLAS Life Sciences worth $516K as of Q2 2026.
  • Kestra Advisory Services bought 5,830 SELLAS Life Sciences shares in Q2 2026, an estimated $40.2K.
  • SELLAS Life Sciences made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2321 holding.
  • Kestra Advisory Services first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.